Neurent Medical develops and markets NEUROMARK, a minimally invasive procedure targeting the posterior nasal nerves to treat chronic rhinitis. The technology is designed to provide durable relief from rhinitis symptoms by addressing the root cause rather than just managing symptoms. The company emphasizes safety, efficacy, and real-time feedback in a clinical ENT setting, with a focus on patients suffering from chronic rhinitis in the United States. Their mission includes transforming lives affected by nasal conditions through innovative treatments.
No recent news for this company.